Year End 2001 – Q102
Study Published in Circulation
Completion of enrollment for PROTECT1 Phase III Oral Heparin Trial
Filled Newly Created Position of President and Chief Operating Officer
FDA review of Trial Design for PROTECT 2 (approved)
Recent Accomplishments/Significant Events